---
title: "GT Biopharma announces annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290245054.md"
description: "GT Biopharma announced its annual shareholder meeting scheduled for August 14, 2026, in Los Angeles. Key agenda items include electing four directors, ratifying Weinberg & Company as the independent auditor, and an advisory vote on executive compensation. Additionally, investors will consider a reverse stock split ranging from 1-for-10 to 1-for-30, accompanied by a reduction in authorized shares. The meeting also covers adding 3.5 million shares to the incentive plan pool and adopting a 2% annual evergreen increase through fiscal 2036."
datetime: "2026-06-18T20:46:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290245054.md)
  - [en](https://longbridge.com/en/news/290245054.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290245054.md)
generator: "portal-rs"
---

# GT Biopharma announces annual shareholder meeting

-   GT Biopharma will hold its annual shareholder meeting in Los Angeles on Aug. 14, 2026. \* Shareholders will vote to elect four directors and to ratify Weinberg & Company as independent auditor for the year ending Dec. 31, 2026. \* An advisory vote on executive compensation is also on the agenda. \* Investors will consider a reverse stock split in a 1-for-10 to 1-for-30 range, paired with a cut in authorized shares to 25,000,000 common and 1,500,000 preferred. \* Other items include adding 3,500,000 shares to the 2022 incentive plan pool and adopting a 2% annual evergreen increase through fiscal 2036. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-029362), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GTBP.US](https://longbridge.com/en/quote/GTBP.US.md)

## Related News & Research

- [Axian Telecom releases Q2 2026 results presentation](https://longbridge.com/en/news/296807653.md)
- [Valion Bio amends 8-K to report final vote tally on reverse stock split approval](https://longbridge.com/en/news/296531983.md)
- [FS KKR Capital hosts shareholder meeting on share issuance proposal vote](https://longbridge.com/en/news/296534123.md)
- [Catheter Precision announces annual shareholder meeting webcast](https://longbridge.com/en/news/296649623.md)
- [Aptevo Therapeutics announces special shareholder meeting](https://longbridge.com/en/news/296649507.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**